Latest period
$899.00M
YoY change
+10.9%
5Y CAGR
+18.4%
Peak year (1998)
$2.23B
Cumulative CapEx
$12.60B
CapEx history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $876.00M
CapEx growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +10.9%
CapEx history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $876.00M | +10.9% | +$86.00M | ||
| 2024 | $790.00M | -1.3% | −$10.00M | ||
| 2023 | $800.00M | +30.7% | +$188.00M | ||
| 2022 | $612.00M | +10.5% | +$58.00M | ||
| 2021 | $554.00M | +47.3% | +$178.00M | ||
| 2020 | $376.00M | -18.4% | −$85.00M | ||
| 2019 | $461.00M | +45.9% | +$145.00M | ||
| 2018 | $316.00M | -0.9% | −$3.00M | ||
| 2017 | $319.00M | -15.2% | −$57.00M | ||
| 2016 | $376.00M | +52.2% | +$129.00M | ||
| 2015 | $247.00M | -4.6% | −$12.00M | ||
| 2014 | $259.00M | +5.7% | +$14.00M | ||
| 2013 | $245.00M | +8.4% | +$19.00M | ||
| 2012 | $226.00M | -25.7% | −$78.00M | ||
| 2011 | $304.00M | +9.4% | +$26.00M | ||
| 2010 | $278.00M | -23.2% | −$84.00M | ||
| 2009 | $362.00M | 0.0% | $0.00 | ||
| 2008 | $362.00M | -0.3% | −$1.00M | ||
| 2007 | $363.00M | +6.5% | +$22.00M | ||
| 2006 | $341.00M | 0.0% | $0.00 | ||
| 2005 | $341.00M | +24.5% | +$67.00M | ||
| 2004 | $274.00M | +45.7% | +$86.00M | ||
| 2003 | $188.00M | +67.9% | +$76.00M | ||
| 2002 | $112.00M | -7.4% | −$9.00M | ||
| 2001 | $121.00M | +59.2% | +$45.00M | ||
| 2000 | $76.00M | -5.0% | −$4.00M | ||
| 1999 | $80.00M | -96.4% | −$2.15B | ||
| 1998 | $2.23B | +837.9% | +$2.00B | ||
| 1997 | $238.20M | +76.1% | +$102.90M | ||
| 1996 | $135.30M | +96.1% | +$66.30M | ||
| 1995 | $69.00M | +92.7% | +$33.20M | ||
| 1994 | $35.80M | 0.0% | $0.00 | ||
| 1993 | $35.80M | +244.2% | +$25.40M | ||
| 1992 | $10.40M | +42.5% | +$3.10M | ||
| 1991 | $7.30M | — | — |
- 2025$876.00M+10.9%
- 2024$790.00M-1.3%
- 2023$800.00M+30.7%
- 2022$612.00M+10.5%
- 2021$554.00M+47.3%
- 2020$376.00M-18.4%
- 2019$461.00M+45.9%
- 2018$316.00M-0.9%
- 2017$319.00M-15.2%
- 2016$376.00M+52.2%
- 2015$247.00M-4.6%
- 2014$259.00M+5.7%
- 2013$245.00M+8.4%
- 2012$226.00M-25.7%
- 2011$304.00M+9.4%
- 2010$278.00M-23.2%
- 2009$362.00M0.0%
- 2008$362.00M-0.3%
- 2007$363.00M+6.5%
- 2006$341.00M0.0%
- 2005$341.00M+24.5%
- 2004$274.00M+45.7%
- 2003$188.00M+67.9%
- 2002$112.00M-7.4%
- 2001$121.00M+59.2%
- 2000$76.00M-5.0%
- 1999$80.00M-96.4%
- 1998$2.23B+837.9%
- 1997$238.20M+76.1%
- 1996$135.30M+96.1%
- 1995$69.00M+92.7%
- 1994$35.80M0.0%
- 1993$35.80M+244.2%
- 1992$10.40M+42.5%
- 1991$7.30M—
CapEx values are taken from Boston Scientific's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's current CapEx (TTM) is $899.00M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Boston Scientific (BSX) reported CapEx of $876.00M – grew 10.9% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Boston Scientific CapEx compounded at +18.4% per year, with mixed annual results across the window.
Between 1998 and 2025, Boston Scientific CapEx plunged 60.8%, falling from $2.23B to $876.00M.
1998 marks the peak CapEx at $2.23B, with the historical low of $7.30M recorded in 1991.
Boston Scientific Capital Expenditures by Year
Boston Scientific Capital Expenditures 2025: $876.00M
Boston Scientific posted CapEx of $876.00M in 2025, grew 10.9% from 2024.
Boston Scientific Capital Expenditures 2024: $790.00M
In 2024, Boston Scientific reported CapEx of $790.00M, edged down 1.3% below 2023.
Boston Scientific Capital Expenditures 2023: $800.00M
Boston Scientific CapEx in 2023 was $800.00M, surged 30.7% from 2022.
Boston Scientific Capital Expenditures 2022: $612.00M
2022's CapEx for Boston Scientific came in at $612.00M, grew 10.5% from 2021.
Boston Scientific Capital Expenditures 2021: $554.00M
Boston Scientific CapEx in 2021 was $554.00M.
See more financial history for Boston Scientific (BSX).
Sector peers by CapEx
Healthcare peers of Boston Scientific (BSX), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation